The objective of this research, led by Andrea Pusic, MD, of Memorial Sloan-Kettering Institute for Cancer Research, is to develop and validate a new, clinically useful patient-reported outcome measure (PROM) of satisfaction and quality of life following elective surgical and non-surgical facial rejuvenation.

The FACE-Q is intended to be easily incorporated in routine clinical practice to measure procedural outcomes. The FACE-Q will provide an important tool with which researchers and clinicians may evaluate the success of various facial aesthetic procedures from a patient perspective.

Support of this research is provided by The Plastic Surgery Foundation and OrthoNeutrogena.